Modernising diagnostic medical microbiology services Professor Brian I. Duerden CBE,MD Emeritus Professor of Medical Microbiology, Cardiff University.

Slides:



Advertisements
Similar presentations
Future Challenges Nigel Edwards Policy Director, NHS Confederation Visiting Professor London School of Hygiene and Tropical Medicine.
Advertisements

Every Cloud has a Silver Lining Ms Maire Bermingham Assistant Director of Corporate Support Services Dr Naomi Baldwin Senior Infection Prevention and Control.
Quality improvement guide: prevention and control of healthcare-associated infections Learning and development resource for board members 2012 NICE public.
Diabetic Foot Problems
National Public Health Performance Standards Program Orientation to the Essential Public Health Services.
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Developments from the National Quality Board: A New Objective for MRSA Derek Butler Registered Charity No
Microbiology without culture - is this the future? Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health.
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
Cap.org v. # Pathologists’ Role in Coordinated Care and Managing Patient Populations.
Addressing safety and security while delivering an effective microbiology service Brian I. Duerden & Sam Gillanders Inspector of Microbiology and Infection.
10 th October 2013 The delivery of 21 st century services – the implications for the evolution of the Healthcare Science workforce Joan Fletcher.
Northern Trust Lymphoedema Stakeholder Event Elaine Stowe Lymphoedema Lead Northern Trust Feb 2010.
Management of a gonorrhoea ‘outbreak’ among university students Gill Bell Nurse Consultant Sexual Health Adviser Sheffield.
Standards for Laboratory Diagnosis of Tuberculosis Professor Brian I. Duerden Inspector of Microbiology and Infection Control, Department of Health.
Scottish Infection Research Network Research Consortia.
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
UNCLASSIFIED Building Biosurveillance Systems for Early Detection of Public Health Events Central Asia Regional Health Security Conference April.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
New Employee Orientation (Insert name) County Health Department.
Driving the HCAI agenda, Widening the net Gaynor Evans.
Clinical Lead Self Care and Prevention
Pathology – Making a Difference To Patient Safety and Quality K Pendry Consultant Haematologist WWL NHS Trust.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Increasing Your Infection Prevention Capacity Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville.
Australian Health Service Safety and Quality Accreditation Scheme Advice Centre Network Meeting Margaret Banks Senior Program Director February 2013.
STRATEGIC PLANNING, LEADERSHIP AND IMPLEMENTATION FOR PATIENT SAFETY Michele McKinnon Director, Safety and Quality SA HEALTH.
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
1 Overcoming Diagnostic Issues and Training Program for Doctors in Hong Kong and China Dr. Ignatius Yu Clinical Professor and Head, Division of Occupational.
WHO guidelines for investigation and control of Foodborne Diseases outbreak Dr. Christina Rundi Ministry of Health, Malaysia.
The Tayside Experience The Long Road To Implementation Peter Rice, Consultant Psychiatrist, NHS Tayside Alcohol Problems Service.
Quality and Safety of Patient Care Elaine Thompson – Deputy Chief Nurse and Quality Officer.
Tackling HCAI in the NHS -strategy and actions Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London.
NHSU Putting learning at the heart of healthcare.
Pathology Modernisation: The Carter Report and implications
Background In May 2003, the Chief Executive announced that the Government had begun to study the establishment of a CDC – like organisation in Hong.
1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Infection Control Clinical Pharmacy and Patient Safety
Implementing universal Lynch Syndrome screening in a large healthcare system.
NHS | Presentation to [XXXX Company] | [Type Date]1 Senates - the interface with SCNs and AHSNs Nigel Acheson Medical Director NHS England (South)
The New Public Health System
Point of Care testing (POCT) For Sexually Transmitted Infections (STI) Barbara Bewley Operations Manager Pathology Clinical Services.
Wessex LETB The Changing Landscape Paul Holmes, Managing Director.
Transforming Community Services Commissioning Information for Community Services Stakeholder Workshop 14 October 2009 Coleen Milligan – Project Manager.
PORTFOLIO COMMITTEE PRESENTATION Ms. Joyce Mogale (Interim CEO) Prof. Perez (Chair ) Supporting a long and healthy life for all South Africans NHLS ANNUAL.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
OPAT in the community Paul Jhass. The Kent IVs in the community experience (holistic nursing care with enhance IV capabilities) Paul Jhass Project Lead.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
New Models of HR Sally Campbell Jane Haire Cheshire HR Service.
1 Prevention, Reablement & Integration. 2 Background We are at an historic time for social care. We have a health and care system too focussed on crisis.
Changes in healthcare commissioning Phil Ambler Operations and Information Manager UK Vision Strategy.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Jane Stockley Chris Catchpole Carole Clive November 2012.
Sometimes you have to be the worst to become the best?  2006: My Region was highlighted as having significantly high admissions for diabetes.  Our performance.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Prof Rakhshanda Rehman, Prof Emeritus,Dean Medical Education,CPSP Prof Emeritus,Dean Medical Education,CPSP. 17 th Health Science Research Symposium 27.
Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
Title of the Change Project
Professor Alan Johnson Department of HCAI & AMR
This is an archived document.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
National Center for Emerging and Zoonotic Infectious Diseases
HOSPITAL INFECTION CONTROL & CURRENT PERCEPTIONS
Presentation transcript:

Modernising diagnostic medical microbiology services Professor Brian I. Duerden CBE,MD Emeritus Professor of Medical Microbiology, Cardiff University

Inspector of Microbiology Champion & promote high quality clinical & public health microbiology –all labs in NHS contribute to surveillance –promote standards & quality –identify gaps in specialist & reference micro. –achieve adherence to SOPs –protocols to reduce the risk of loss/misuse –compliance with security and health & safety

Vision and Goal An integrated and cohesive, quality assured microbiology and virology service to support clinical care of patients with infection and for health protection.

…….2011 Microbiology and Virology service – I nfection Service Health Protection – Public Health

Slow progress….why? Pathology modernisation –2005 visits and report highly variable but little concrete action highly variable but little concrete action –Carter review and pilots HPA establishment –Hiatus for public health microbiology HCAI prominence –MRSA and C. difficile targets –Intense effort 30 years in the “backroom”

Parting of the ways Microbiology & Infection Control –New antibiotics –New societies –New journals –New guidelines –New diseases Infection control was the province of the IC specialists Modern medicine –Increased life expectancy –Cancer treatment Immunosuppression –Complex surgery Cardiac Neurosurgery Orthopaedic –Chronic illnesses Infection – a nuisance

1990s – the backroom days Increasing –HCAI MRSA Clostridium difficile AcinetobacterNorovirus –Antimicrobial resistance ESBL –Pandemic threats –Need for microbiology!! Decreasing –Training numbers –Academic input Reduced medical student impact Effect of RAE Dislocation of academic/service interface –Training in asepsis –Supply of microbiologists!!

BUT…….. ….we did not help ourselves

Perceived dogmas Laboratory focused –What about patient focus? Individual clinical pathology disciplines A lab in every main hospital/trust Transport too difficult – delays Lab headed by medical microbiologist –Medical microbiologists based in labs –Unwilling to have cover from a distance Daytime (8.30 – 17.30) service –On-call out of hours

Results Traditional methods Lack of investment in –new technology, IT Lack of specialisation Isolated services

Where do we go from here?

Coalition Government & NHS reorganisation Infection (prevention &control) is a priority Commissioning by GP Consortia –Need for support and guidance –Potential role for revised National Standards for Microbiology (standard methods) with Professional bodies’ ownership Public Health Service –Within DH –National and local components –Incorporates HPA functions (incl. labs) How will Public Health Microbiology be delivered?

Post-Carter developments Various models – same aims –Consolidation, centralisation –Enable technology development Automation - conventional tests; new technology Molecular, post-genomic – sequencing, micro-array, MALDI- TOF –Concentrate staff expertise –Extended (24/7) working –Cost effectiveness ………maintain the quality of patient care and public health support

Public Health responsibility HPA (Public Health England) –Public health, specialist, reference microbiology Clinical/diagnostic laboratories –NHS or commissioned Surveillance reporting Notifiable diseases Outbreak identification and support Standardised methods for infections of public health importance

Communicable diseases legislation 2010 Act – Notifiable diseases Requires all diagnostic laboratories to report isolates of pathogens with Public Health significance –Much longer list –In addition to medical practitioners reporting clinical cases –Expectation of accreditation and use of standard methods 2008 Code of Practice for HCAI –Requires microbiology support from an accredited laboratory

Technology developments Automation –Conventional tests –Molecular, post-genomic Which technologies –Next generation sequencing –Micro-arrays –MALDI-TOf –?????? …we need a strategy for their use

UKCRC - TIRI Oxford –Application of sequencing to diagnostic and public health microbiology; eg, HCAIs Imperial –Changing the culture and embedding HCAI prevention & control in healthcare services –Linked to modern diagnostics for HCAI epidemiology St Georges –POC molecular testing and mobile communication modules for STI Cambridge –Sequencing developments for MRSA and web-based systems for analysing data generated remotely

POC testing Healthcare settings –ICU –MRSA screening in A&E etc …need to be integrated with laboratory service “High Street”settings –Increase accessibility for patients/clients –Professional oversight? Interpretation? Advice? –Links to patient record? –Risks loss of surveillance data for public health …Microbiologists need to be involved in pilot projects

Transforming medical specialist training Medical roles of infection specialists –Clinical patient care –Consultation/advice What investigations? Interpretation of results Antimicrobial treatment Epidemiology Infection prevention and control Common training pathway –Core infection training –Clinical care, diagnostic & public Health microbiology/virology, infection prevention & control

Challenges for the future Keep infection as a patient safety priority in healthcare It will never go away! Use modern technology to deliver a patient-focused service Do not repeat the mistakes of